XML 68 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 08, 2020
May 11, 2018
Jan. 31, 2021
Oct. 31, 2020
May 27, 2019
Feb. 24, 2015
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Sep. 07, 2021
Feb. 07, 2021
Jul. 01, 2020
Feb. 27, 2019
Jan. 21, 2019
Related Parties Transactions (Details) [Line Items]                                    
Principal amount             $ 650,000   $ 650,000         $ 67,873 $ 104,167     $ 1,000,000
Loan agreement, description                         The advances bear interest rate from 12% to 13.6224% per annum.          
Outstanding advance                 703     $ 0            
Accrued interest             167,294   167,294     166,261            
Due from Rgene             1,621   $ 1,621     $ 0            
Interest rate percentage     0.00%           1.50%                  
Interest rate, percentage                       2.10%            
Aggregate working capital                 $ 59,392   $ 0              
Loan agreement, description       the Company has advanced an aggregate amount of $1,610 to Keypoint for working capital purpose. Under the terms of the loan agreement, the loan bears interest at 6.5% per annum and the loan will be matured on October 30, 2021. The amount was settled during the third quarter of 2021. As of September 30, 2021 and December 31, 2020, the outstanding loan balance was $1,610 and $1,610, respectively.                            
Outstanding advance balance             298,269   $ 298,269     $ 288,445            
Advance bears interest rate                 0.00%                  
Interest expenses             5,679   $ 16,670                  
Accrued employee amounted             0   0     72,704            
YuanGene [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Aggregate working capital                 9,205                  
Rgene Corporation [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Principal amount             47,756   $ 47,756     42,911            
Loan agreement, description                 Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the maturity date was December 31, 2020.                  
Outstanding advance                 $ 33,431     31,684            
Accrued interest             12,704   $ 12,704     11,227            
BioFirst [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Loan agreement, description                 The advances bear interest 1% per month (or equivalent to 12% per annum).                  
Outstanding advance balance             19,611   $ 19,611   $ 23,647              
Asiangene Corporation [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Outstanding advance                 0     3,560            
Accrued interest             0   $ 0     681            
Interest rate percentage                 0.00%                  
Aggregate working capital                 $ 24,017     0            
BioFirst (Australia) [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Principal amount   $ 40,000                           $ 361,487    
Outstanding advance                 $ 234,606     373,235            
Advances bear interest, description   The advances bear 0% interest rate and are due on demand prior to September 30, 2020.                                
Interest rate percentage   12.00%             6.50%                  
BioLite Taiwan [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Loan agreement, description           The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                        
Due from BHK             $ 124,625 $ 123,583 $ 124,625 $ 123,583                
Interest rate, percentage                                 0.00%  
LBG USA, Inc.[Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Outstanding advance                 675 675                
BioLite Japan [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Loan agreement, description Based on the LOI, each party will advance an aggregated amount of $150,000 to meet BioLite Japan’s working capital needs, which the Company advanced an amount of $150,000 and the advance bear 0% interest rate.                                  
Outstanding advance                 150,000     150,000            
Aggregate working capital $ 150,000                                  
JIANGS [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Aggregate working capital                 $ 18,750     $ 16,627            
Interest expenses               $ 5,440   $ 17,430                
Minimum [Member] | JIANGS [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Interest rate percentage                 0.00%                  
Maximum [Member] | JIANGS [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Interest rate percentage                       1.00%            
Conversion Agreements One [Member] | BioFirst [Member]                                    
Related Parties Transactions (Details) [Line Items]                                    
Stock purchase agreement, description         the Company entered into loan agreements with AsiaGene for NT $100,000, equivalent to $3,560, to meet its working capital needs.  Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the loan maturity date was December 31, 2020.